What You Should Know:
Viome, a leading innovator of health technology and personalized health solutions, is partnering with Henry Schein to provide better access to Viome’s Oral Health Pro™ With CancerDetect™.Viome’s laboratory-developed test helps detect early…
Continue Reading
Progress in sequencing technologies and clinical experiments has revolutionized immunotherapy on solid and hematologic malignancies. However, the benefits of immunotherapy are limited to specific patient subsets, posing challenges for broader application. To improve its…
Continue Reading
University College Dublin is leading a team that is working on a research initiative that could help transform pre-eclampsia diagnosis using technology from SAS.A solution has been developed that will support clinicians to make…
Continue Reading
What You Should Know: – PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. – The expansion doubles the platform’s reach,…
Continue Reading
Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) has unveiled the companies set to join the 2024 cohort for its Advanced Wellbeing Accelerator programme. The prestigious six-month accelerator programme, which will support 10 start-ups and…
Continue Reading
Tech-enabled heart disease detection company CardioSignal announced it secured $10 million in Series A funding, bringing its total raise to $23 million. DigiTx Partners led the round. Sandwater also participated alongside existing investor Maki.vc.
Dr. David…
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
What You Should Know: – Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja. – The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after…
Continue Reading
Parkinson’s disease (PD) exhibits significant clinical heterogeneity, presenting challenges in the identification of reliable electroencephalogram (EEG) biomarkers. Machine learning techniques have been integrated with resting-state EEG for PD diagnosis, but their practicality is constrained…
Continue Reading
